Literature DB >> 32992475

New Real-Time PCRs to Differentiate Rickettsia spp. and Rickettsia conorii.

Valeria Blanda1, Rosalia D'Agostino1, Elisabetta Giudice2, Kety Randazzo1, Francesco La Russa1, Sara Villari1, Stefano Vullo1, Alessandra Torina1.   

Abstract

Rickettsia species are an important cause of emerging infectious diseases in people and animals, and rickettsiosis is one of the oldest known vector-borne diseases. Laboratory diagnosis of Rickettsia is complex and time-consuming. This study was aimed at developing two quantitative real-time PCRs targeting ompB and ompA genes for the detection, respectively, of Rickettsia spp. and R. conorii DNA. Primers were designed following an analysis of Rickettsia gene sequences. The assays were optimized using SYBR Green and TaqMan methods and tested for sensitivity and specificity. This study allowed the development of powerful diagnostic methods, able to detect and quantify Rickettsia spp. DNA and differentiate R. conorii species.

Entities:  

Keywords:  R. conorii; Rickettsia spp.; ompA; ompB; real-time PCR

Mesh:

Substances:

Year:  2020        PMID: 32992475      PMCID: PMC7582818          DOI: 10.3390/molecules25194431

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

The Rickettsia genus (order Rickettsiales; family Rickettsiaceae) includes obligate intracellular, slow-growing Gram-negative bacteria, representing an important cause of emerging vector-borne diseases [1]. These bacteria can be transmitted to animals and humans by blood-sucking arthropods, causing specific zoonotic diseases termed rickettsioses, among the oldest known vector-borne diseases [2,3]. Ticks are the main vectors, although the pathogen can also be transmitted by other arthropods, such as fleas, lice, or mites, with some evidence also for mosquitoes for some Rickettsia species (e.g., Rickettsia felis) [4,5,6]. The Rickettsia genus encompasses several species, and the most widely used classification of Rickettsia spp. within this genus includes the spotted fever group (SFG), typhus group (TG), Rickettsia bellii group, and Rickettsia canadensis group [7]. The SFG Rickettsia species comprise two major subgroups: The Rocky Mountain Spotted Fever (RMSF) group, to which R. rickettsii belongs, and the Mediterranean Spotted Fever (MSF) group, including R. conorii [8]. MSF due to R. conorii is endemic in the Mediterranean area, including northern Africa and southern Europe. It has also been described in sub-Saharan Africa, and some cases have also been reported in northern and central Europe [9]. The disease is an emerging or re-emerging disease in some regions, while in some other Mediterranean countries MSF incidence has increased during recent years [10,11]. This could be explained by global warming producing an increase in tick bites [12]. After a tick bite, bacteria replication within the infection site can lead to a necrotic lesion (eschar), and endothelial cells are the first cellular targets for rickettsia infection, with severe vascular damage [13]. MSF symptoms include fever, headache, and maculopapular rash; an eschar at the tick-bite site can also be present [14]. The disease usually has a benign course, but severe complications are reported in about 6% of cases, with patients showing severe vasculitis with renal and other organ involvement and multiorgan failure [4]. Fatal outcomes can occur even in healthy adults, with a 2.5% reported death rate [15,16]. For many years, MSF diseases due to R. conorii conorii were thought to be the only tick-borne rickettsial diseases found in southern and eastern Europe. However, in recent years, the amplification and sequencing of different molecular markers has allowed the identification of new Rickettsia species or subspecies within the SFG group involved in human rickettsiosis, such as R. conorii israelensis, R. conorii caspia, R. aeschlimannii, R. slovaca, R. sibirica, R. mongolitimonae, and R.massiliae [17,18]. These species are considered as emerging pathogens [19], and in many cases they are characterized by distinct clinical features and defined geographic locations [14]. In Italy, SFG rickettsiosis is a mandatory notifiable disease since 1990; nevertheless, due to under-notification and under-diagnosis of cases, the true incidence of the disease remains unknown. As in other Mediterranean countries [20], MSF caused by R. conorii is the predominant SFG SFGrickettsiosis. A recently published study estimated a total of 5989 cases of SFG rickettiosis in Italy from 2001 to 2015, with an average annual incidence of 0.88/100000 people and a mean annual standardized hospitalization rate of 1.36/100000 people/year. In particular, cases were strongly concentrated in Sicily and Sardinia, in the southern part of Calabria, and in the southern coastal provinces of the Lazio region [21]. Several methods have been developed for diagnosis of rickettsioses. Serological tests are the easiest methods but data interpretation is often complicated by the cross-reactivity among the species [22]. Rickettsia species identification involves molecular methods based on PCR amplification and sequencing of various rickettsial genes; however, the procedure is time-consuming. Real-time PCR (RT-PCR) is a rapid and sensitive method, and quantitative methods based on RT-PCR have been developed for rickettsial agent detection [23,24,25,26]. Genomic approaches have recently increased our knowledge on Rickettsia spp., and massive amounts of genomic data have become available. We used published genomic sequence data to design new sets of primers and probes for RT-PCRs targeting the ompB and ompA genes. These two genes codify for two outer-membrane proteins widely investigated due to their exposed cellular location and the presence of conserved epitopes. Both genes are also commonly employed for phylogenetic analysis due to their significant variability among species [27]. The aim of this study was to improve the diagnosis of Rickettsia infections by developing two new RT-PCRs, able to quickly and reliably detect Rickettsia spp. DNA and to discriminate, without sequencing, R. conorii infection, which is of particular importance since it occurs with high frequency in Mediterranean area, in both humans and animals.

2. Results

The newly developed RT-PCR assays showed high sensitivity and specificity. The detection limit of both assays, based on the standard curve dilutions, resulted to be less than 10 DNA copies, while, as regards the conventional PCRs most commonly used for Rickettsia species diagnosis [3], we obtained a sensitivity of 100 copies of DNA for single-step PCRs and 10 copies of DNA for nested PCRs (data not shown). Positive controls were correctly identified. The assays showed good reproducibility when standards were tested in duplicate. In particular, Figure 1A shows customary values obtained for the standard curve (r = 1; slope = −3.353) of the SYBR Green RT-PCR for Rickettsia spp. based on the amplification of an ompB fragment. Melting temperature analysis showed that the reaction was specific (Figure 1B).
Figure 1

Customary values obtained for the standard curve (A) and melting temperature analysis (B) of the SYBR Green RT-PCR for Rickettsia spp. based on the amplification of an ompB fragment.

The reaction resulted to be positive for all the analyzed Rickettsia species (Figure 2A). Amplification was observed only in those samples previously selected as positive to Rickettsia spp. Samples positive for other tick-borne pathogens belonging to Anaplasma, Ehrlichia, Babesia, and Theileria genera resulted to be negative (Table 1).
Figure 2

(A) Rickettsia species amplification by the new SYBR Green RT-PCR for the ompB gene and (B) the new TaqMan RT-PCR for the ompA gene. (R1: R. conorii; R2: R. aeschlimannii; R3: R. massiliae; R4: R. raoultii; R5: R. monacensis; R6: R. helvetica; R7: R. slovaca; R8: R. felis; R9: Rickettsia endosymbiont of Haemaphysalis sulcata; and R10: Candidatus Rickettsia hoogstraalii)

Table 1

Results of the amplification with the two new methods in the presence of DNA from different Rickettsia species and from other tick-borne pathogens.

Rickettsia spp. RT-PCR(ompB)R. conorii RT-PCR(ompA)
R. conorii ++
R. aeschlimannii +-
R. massiliae +-
R. raoultii +-
R. monacensis +-
R. helvetica +-
R. slovaca +-
R. felis +-
Rickettsia endosymbiont of Haemaphysalis sulcata+-
Candidatus Rickettsia hoogstraalii+-
Babesia bigemina --
Babesia bovis --
Theieleria annulata --
Ehrlichia canis --
Anaplasma marginale --
Anaplasma ovis --
Anaplasma phagocytophilum --
For the exclusive amplification of R. conorii, a set of primers and probe was designed to selectively detect R. conorii DNA. The reaction was performed with the TaqMan method. The customary values obtained for the standard curve (r = 0.967 and a slope value of −3.185) are reported in Figure 2B. The analysis carried out with DNA from different Rickettsia species showed the presence of fluorescence only in the presence of R. conorii DNA. All the other Rickettsia species were negative as well as the samples positive for the other tick-borne pathogens (Table 1).

3. Discussion

The Rickettsia genus encompasses several species with differences in antigenic and microbiological characteristics, distribution, ecology, pathogenicity, and association with arthropod hosts [28,29]. New rickettsial syndromes have been described that are associated with the different Rickettsia species. In some cases, such as for R. aeschlimannii and R. monacensis, an MSF-like disease has been reported, while for other species, such as R. raoultii or R. slovaca, different clinical symptoms have been described [4]. Moreover, some species could cause severe or even lethal outcomes in subjects with predisposing conditions. For example, a fulminant course of R. conorii israelensis infection has been correlated with glucose-6-phosphate dehydrogenase deficiency [16,30]. In addition, a different antibiotic susceptibility among different Rickettsia species has been reported. Doxycycline is the treatment of choice showing the greatest efficacy against the majority of SFG Rickettsia species. Erythromycin and rifampicin show a variable efficacy. Rifampicin is often used when treatment with tetracycline is contraindicated, such as in children. R. conorii does not exhibit resistance to rifampicin, while other species such as R. massiliae, R. montanensis, R. rhipicephali, R. aeschlimannii, Catalan isolate Bar29, and R. felis were more resistant [28,31,32,33,34]. The rifampicin resistance observed for R. massiliae is probably associated with mutation of rboB [34]. Moreover, the availability of sensitive and reliable molecular tests is essential for conducting studies on the prevalence and endemicity of a particular species in a territory, which are essential for delimiting the areas of circulation of the species. All these considerations explain the increasing need for sensitive diagnostic tools to identify emerging and re-emerging rickettsial infections. Traditional molecular methods for Rickettsia species identification are consuming and expensive, since, for example, they are based on the amplification of pathogen DNA followed by the endonuclease fragment length polymorphism (RFLP), or a multigenic approach founded on simultaneous analysis and sequencing of many loci, such as atpA, recA, dnaA, ompA, ompB, and gltA [35]. The sensitivity of the traditional PCRs more commonly used for Rickettsia diagnosis is around 100 copies of rickettsial DNA protein [16,36]. Higher sensitivities are obtained for nested PCRs; however, they show numerous drawbacks, since they are time-consuming and show a higher risk of sample contamination, being two-step methods. For this reason, in recent years several laboratories have implemented new molecular tests for the identification of Rickettsia species [23,24,37,38,39,40,41,42]. An RT-PCR based on the rickettsial gltA gene was developed that allows the amplification of DNA from members of the Rickettsia genus. The assay is highly sensitive (1 copy of target DNA) [24]. Afterwards, a multiplex RT-PCR assay was implemented to differentiate between scrub typhus group, typhus group, and spotted fever group rickettsiae using 47kDa, gltA, and ompB gene targets [37]. The assay is SYBR Green-based, and the differentiation among groups is obtained by melt-curve analysis. A pan-rickettsial RT-PCR was developed by Giulieri and collegues [38], amplifying a segment of the 16S rRNA gene of Rickettsia spp. The assay is combined in a duplex RT-PCR also amplifying a gltA target from the TG rickettsiae. The method showed good analytical sensitivity and specificity. Another study developed two diagnostic RT-PCRs [39]. The first is a pan-rickettsial RT-PCR targeting the 23S rRNA, and the second is an RT-PCR specific for R. rickettsii species and targeting a fragment of a gene encoding the hypothetical protein A1G_04230. A sensitivity limit of 8–9 genome copies for both the assays was reported. A specific multiplex RT-PCR assay has been developed for the detection of R. rickettsii, R. parkeri, and R. akari specimens [40]. These species are indigenous to the United States and are the etiologic agents of Rocky Mountain spotted fever, rickettsialpox, and R. parkeri rickettsiosis, respectively. In particular, the assays aimed to amplify small but specific DNA fragments of these species from a formalin-fixed, paraffin-embedded skin biopsy, overcoming the difficulty of obtaining large gene segments from formalin-fixed tissues that are usually targeted by the majority of available PCRs. Primers and probes targeted a hypothetical protein gene of the R. rickettsii genome and the ompB genes of R. parkeri and R. akari. As regards the diagnosis of SFG Rickettsia, an RT-PCR was developed by Kidd and colleagues [23] for detection of SFG Rickettsia species in dog blood. The assay amplifies a small region of the ompA gene and shows a sensitivity range between 1 and 10 copies of target DNA. Species discrimination could be obtained by sequencing the smaller amplified region. Other protocols have been developed to identify some of the new emerging Rickettsia species that are agents of SFGin the Mediterranean basin. In particular, a first study implemented two new TaqMan probe-based RT-PCR assays targeting the ompA gene for the identification of R. aeschlimannii and R. africae [41]. The assays showed high specificity and sensitivity, with the detection limit resulting to be less than 10 DNA copies. In a second study, three RT-PCR assays targeted fragments of the ompB gene of the species R. raoultii, R. slovaca, and R. aeschlimannii [42]. The methods are based on species-specific molecular beacon or TaqMan probes and resulted to be specific and sensitive (limit of detection was at least 3 copies per reaction for all the assays). Our work continues the efforts to improve the diagnosis of Rickettsia spp. The protocols developed here maintain high standards of sensitivity comparable with those of the methods reported above. In addition to what can be achieved using the methods already published, our new method also allows identification of R. conorii, the main agent of MSF in the Mediterranean basin, without sequencing, thus saving time and costs. The methods described here are based on the amplification of two genes widely used in the characterization of rickettsiae. The two genes encode outer membrane proteins and contain regions highly conserved among the different species as well as hypervariable regions. In particular, the rickettsial ompA gene is considered an attractive target for detecting and differentiating Rickettsia species by molecular methods since this well-characterized gene exhibits significant variability among species [26,43]. Sequence analysis carried out in our study confirmed that the significant variability of the ompA and ompB genes makes them good targets to be used in diagnostic analyses. A region of the ompB gene, conserved among Rickettsia species, has been used to design a set of Rickettsia genus-specific primers. Conversely, within the ompA gene we identified a variable region among Rickettsia species, which has been used for primer and probe annealing to carry out an assay highly specific for R. conorii. In conclusion, this study allowed the development of two new methods able to detect and quantify Rickettsia spp. pathogen DNA and also to discriminate R. conorii from other Rickettsia species (R. aeschlimannii, R. massiliae, R. raoultii, R. monacensis, R. helvetica, R. slovaca, R. felis, Rickettsia endosymbiont of Haemaphysalis sulcata, and Candidatus Rickettsia hoogstraalii) that are frequently detected [3,11,18,29,44,45]. Customary values obtained for the standard curve of both reactions indicate that the reactions were well-optimized. The methods reduce contamination risk and show accurate quantization of pathogen DNA and high sensitivity. Moreover, the new assays are rapid and easy to perform, and could therefore be easily implemented in laboratories with molecular facilities and added to existing molecular tools. It was reported that the development of RT-PCRs for the diagnosis of rickettsioses reduces the delay in the diagnosis of rickettsial infections and allows improvements in the efficiency of managing patients with suspected cases of rickettsiosis [46,47]. All these characteristics of the new developed methods are significant, as the rapid diagnosis of rickettsial diseases is crucial for an effective treatment of the illness.

4. Materials and Methods

4.1. Rickettsia Conorii Malish 7 Strain Culture

R. conorii Malish 7 strain (ATCC® VR-613™) was cultured in VERO cells, a lineage of cells isolated from kidney epithelial tissue of African green monkey. Cells were maintained at 37 °C, in a humid atmosphere with 5% CO2, using the growth medium MEM (Minimal Essential Medium buffered-salt, Sigma, St. Louis, MO, USA), supplemented with penicillin 50 IU/mL, streptomycin 100 g/mL, amphotericin 2.5 g/mL, and fetal calf serum at 10%. The strain was used as the reference material for standardization and optimization of the RT-PCRs and to evaluate the sensitivity of the assays.

4.2. Field Samples for Specificity Analyses

In order to analyze the specificity of the new assays, DNA was extracted from field samples (vertebrate hosts or ticks), humans, or R. conorii cell cultures using the PureLink Genomic Mini kit (Applied Biosystems, Waltham, MA USA) and quantified using a Nanodrop ND1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). DNA samples were analyzed through PCRs for Rickettsia spp. [48,49,50], Anaplasma spp. [51,52,53], and Ehrlichia spp. [54], and by Reverse Line Blot for Babesia spp. and Theileria spp. [55]. PCRs were performed in a reaction buffer containing 1.5 mM MgCl2, 0.2 mM dNTPs, 0.4 mM primers, and 0.025 U/μL of Taq polymerase (5 U/μL) (Promega, Madison, WI, USA). PCR products were visualized after electrophoresis in a 2% agarose gel with 1X SYBR Safe. PCR products from Rickettsia spp. positive samples were purified by Wizard® SV Gel and PCR Clean-Up System (Promega, Madison, WI, USA) and sent for sequencing (Macrogen Inc., Amsterdam, The Netherlands). Sequences analysis was performed by MEGA software [56], and comparison of obtained sequences with the ones present in Genbank was conducted using the Basic Local Alignment Search Tool (BLAST).

4.3. Primer Design and Selection

OmpB and ompA gene sequences from many different Rickettsia species (Table 2) were selected from GenBank and aligned using Clustal W in order to identify the appropriate region for primer design using the Primer Express 3.0 software.
Table 2

Accession numbers of ompB and ompA gene sequences from many different Rickettsia species selected from GenBank and used in this study for primer and probe design and for in silico specificity analysis.

Rickettsia SpeciesompBGenBank Acc. n.ompAGenBank Acc. n.
R. conorii conorii AF123721.1U43806
R. conorii Indian tick typhus AF123726.1597U437
R. conorii subsp. Caspia AY643093.1167U4379
R. conorii Israeli tick typhus AF123712.1U43797
R. massiliae AF123714.1U43799
R. raoultii DQ365798.1DQ365801S1
R. aeschlimannii AF123705.1DQ379982
R. slovaca AF123723.2U43808
R. monacensis EF380356.1FJ919650
R. helvetica AF123725.1
R. rhipicephali AF123719.1U43803
R. felis GQ385243HM636635
Candidatus R. hoogstraalii EF629536.1
Rickettsia endosimbiont of I. scapularisEF433951.1
R. mongolotimonae DQ097083.1DQ097082.1
R. sibirica AF123722.1 U43807
R. africae AF123706.1U43790
R. honei AF123711.1U43809
R. rickettsii X16353.1U43804
R. montanensis AF123716.1U43801
R. parkeri AF123717.1U43802
R. japonica AB003681.1U43795
R. prowazekii DQ926859.1
R. australis AF123709.1
R. heilongjiangensis AY260451.1
R BAR-29 RBU43792

Acc. n.: Accession Number.

The designed Rickettsia genus-specific primer sequences for SYBR Green RT-PCR are qOmpBFw (CAGCCTGACAGAACCGCTAAA) and qOmpBRev (CGATTCCGTACTCCAATCTTAGCA), targeting the ompB gene. The amplified fragment of the ompB gene was 84 bp. For R. conorii-specific RT-PCR, primers and probe were designed in a region of the ompA gene where differences between R. conorii and the other Rickettsia species occurred (Figure 3). The new primers are OmpARTFw (CGGGGCACTCGGTATTGCTGTTT) and OmpARTRev (GCGAGCAGGAGTACCATTAGC), and the probe is RconOmpAProbe1 5′-FAM (GCAATAATTGGAATGAGATAACGGCTGC)-3′TAMRA. The amplified fragment of the ompA gene was 129 bp. The quencher at the 3′ end (tetramethylrhodamine, or TAMRA) absorbs the fluorescence of the dye label (6-carboxyfluorescein, or FAM) present at the 5′ terminus of the probe. When the probe is incorporated in the target sequence and amplification occurs, the dye is removed by the 3’ to 5’ exonuclease activity of the Taq polymerase and it is free to release fluorescence that can be specifically detected by the instrument (Figure 4).
Figure 3

Region of the ompA gene in which the primers and the probe for the RT-PCR specific for R. conorii have been designed. The sequence of R. conorii in this region differs from that of other Rickettsia species.

Figure 4

(A) Fluorescence of FAM fluorophore at the 5′ end of the probe is quenched by the TAMRA (quencher) present at the 3′ end. (B) During the annealing step of the RT-PCR, the probe is incorporated in the target sequence. (C) Exonuclease activity of the Taq polymerase during the amplification degrades the probe, and the fluorophore can release the fluorescence.

4.4. Cloning and Sequencing of PCR Products

In order to obtain the standards for the RT-PCR, a PCR with the designed primers was carried out on the DNA extracted from R. conorii conorii Malish 7 strain cultured in VERO cells using the conditions previously described and an annealing temperature of 60 °C. PCR products were purified, inserted into the cloning vector pCR2.1 TOPO TA (Applied Biosystems, Waltham, MA USA), and propagated in Escherichia coli (One Shot TOP10 Chemically Competent E. coli, Life Technologies, Carlsbad, CA, USA). Plasmid DNA was extracted using the Wizard purification system SV minipreps DNA purification system (Promega, Madison, WI, USA), quantified using a Nanodrop ND1000 Spectrophotometer, and sent for sequencing (Macrogen Inc., Amsterdam, The Netherlands). To obtain a series of standards covering a range from 10 to 108 copies of DNA/μL, 1:10 serial dilutions were prepared; aliquots of these dilutions were stored at −20 °C and thawed only once.

4.5. Real-Time PCR Optimization

RT-PCRs were carried out in a CFX96 Termocycler (Biorad, Hercules, CA, USA). For the assay optimization, different annealing temperatures (58, 60, and 62 °C) and primer concentrations (0.25, 0.5, and 0.8 µM) were tested. Each reaction was performed in duplicate and in the presence of at least a no-template control. SYBR Green RT-PCR final protocol included a final volume of 20 µL comprising 10 µL of ITaq SYBR Smx Rox (Biorad, Hercules, CA, USA), 0.5 μM of primers, and 2 μL of template DNA. The final thermal protocol comprised 95 °C for 15 s, followed by 40 cycles each comprising a step at 95 °C for 15 s and an annealing/elongation at 60 °C for 1 min. TaqMan reactions were carried out using the previously described thermal protocol in a final volume of 20 µL comprising 10 µL of VeriQuest Probe qPCR Master Mix (Applied Biosystems, Waltham, MA, USA), 0.5 μM of primers, 0.25 μM of probe, and 2 μL of template DNA. Fluorescence increase was detected during the polymerization phase and data were analyzed by the CFX Manager 1.6 software.

4.6. Specificity and Sensitivity of the New Assays

Specificity was verified both in silico using blast analysis on the GenBank database and in vitro using R. conorii (ATCC cultured in VERO cells) and testing a local collection panel of DNAs belonging to different Rickettsia species previously identified sequencing Rickettsia reference genes (ompB, ompA, and gltA). In particular, tested samples included R. massiliae (KM081694, KM081702, KM115409), R. aeschlimannii (KM081686, KM081699, KM115415), R. raoultii (KM081695), R. monacensis (KM081687, KM081697, KM115411), R. helvetica (KM081691, KM115413), R. slovaca (KM081689, KM081700, KM115410), R. felis (KM006784, KM006812, KM006832), Rickettsia endosymbiont of Haemaphysalis sulcata (KM081684), and Candidatus Rickettsia hoogstraalii (KM081685). Assay specificity was also tested in the presence of DNA from pathogens other than Rickettsia such as Anaplasma, Ehrlichia, Babesia, and Theileria. Sensitivity was determined using 10-fold serial dilutions of the standards from 107 to 10-1 DNA copies per reaction.
  55 in total

1.  Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever.

Authors:  G Regev-Yochay; E Segal; E Rubinstein
Journal:  Isr Med Assoc J       Date:  2000-10       Impact factor: 0.892

2.  Fatal cases of Tick-borne fever (TBF) in sheep caused by several 16S rRNA gene variants of Anaplasma phagocytophilum.

Authors:  S Stuen; S Nevland; T Moum
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

3.  Current knowledge of rickettsial diseases in Italy.

Authors:  Lorenzo Ciceroni; Antonella Pinto; Simonetta Ciarrocchi; Alessandra Ciervo
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

4.  Detection of Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari in skin biopsy specimens using a multiplex real-time polymerase chain reaction assay.

Authors:  Amy M Denison; Bijal D Amin; William L Nicholson; Christopher D Paddock
Journal:  Clin Infect Dis       Date:  2014-05-14       Impact factor: 9.079

5.  Widespread use of real-time PCR for rickettsial diagnosis.

Authors:  Aurélie Renvoisé; Jean-Marc Rolain; Cristina Socolovschi; Didier Raoult
Journal:  FEMS Immunol Med Microbiol       Date:  2011-12-08

6.  A retrospective study of the characterization of Rickettsia species in ticks collected from humans.

Authors:  Valeria Blanda; Alessandra Torina; Francesco La Russa; Rosalia D'Agostino; Kety Randazzo; Salvatore Scimeca; Elisabetta Giudice; Santo Caracappa; Antonio Cascio; José de la Fuente
Journal:  Ticks Tick Borne Dis       Date:  2017-04-12       Impact factor: 3.744

7.  Gene sequence-based criteria for identification of new rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov.

Authors:  Pierre-Edouard Fournier; J Stephen Dumler; Gilbert Greub; Jianzhi Zhang; Yimin Wu; Didier Raoult
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 8.  Tick-borne rickettsioses in Europe.

Authors:  José A Oteo; Aránzazu Portillo
Journal:  Ticks Tick Borne Dis       Date:  2012-11-21       Impact factor: 3.744

9.  Questions on Mediterranean spotted fever a century after its discovery.

Authors:  Clarisse Rovery; Philippe Brouqui; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

10.  A molecular survey of Rickettsia felis in fleas from cats and dogs in Sicily (Southern Italy).

Authors:  Elisabetta Giudice; Simona Di Pietro; Antonio Alaimo; Valeria Blanda; Rossella Lelli; Francesco Francaviglia; Santo Caracappa; Alessandra Torina
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more
  3 in total

1.  Renal Involvement in Mediterranean Spotted Fever: Clinical and Histopathological Data.

Authors:  Ivan Baltadzhiev; Zaprian Zaprianov; Atanas Baltadjiev
Journal:  Med Princ Pract       Date:  2021-03-29       Impact factor: 1.927

Review 2.  Immune Response to Tick-Borne Hemoparasites: Host Adaptive Immune Response Mechanisms as Potential Targets for Therapies and Vaccines.

Authors:  Alessandra Torina; Valeria Blanda; Sara Villari; Antonio Piazza; Francesco La Russa; Francesca Grippi; Marco Pio La Manna; Diana Di Liberto; José de la Fuente; Guido Sireci
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

3.  Visual closed dumbbell-mediated isothermal amplification (CDA) for on-site detection of Rickettsia raoultii.

Authors:  Zheng Gui; Hao Cai; Lin Wu; Qing Miao; Jing Feng Yu; Ting Cai; Rui Mao
Journal:  PLoS Negl Trop Dis       Date:  2022-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.